Trial intelligence / Profile preview

Dose-response of prophylactic metaraminol for hypotension after general anesthesia induction in elderly patients

ChiCTR2500114230Phase 4Not yet recruiting

Sponsor
Wenzhou Hospital of Traditional Chinese and Western Medicine
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of metahydroxylamine in hypotension (4 arms), sponsored by Wenzhou Hospital of Traditional Chinese and Western Medicine. Primary endpoint: Incidence of hypotension. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

metahydroxylamine
03

Conditions

hypotension

Beyond the preview

Go deeper on ChiCTR2500114230.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500114230.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call